Abstract
Inhalation therapy remains a suitable approach to treat lung diseases including cancer. This approach has been used to deliver various therapies including chemotherapy. The rationale for using the inhalation route vs. the systemic route has been the fewer side effects encountered when drugs are administered via inhalation. Furthermore, this approach overcomes one of the major limitations of systemic chemotherapy that results from inability of the drug to reach high concentrations in the lungs. Local delivery overcomes this limitation and spares exposure of vital organs to the drug, resulting in a more effective delivery system.
Pulmonary metastasis of osteosarcoma (OS) remains a major cause of death and is very difficult to treat. Using various OS mouse models, we demonstrated that aerosol chemotherapy causes regression of pulmonary metastases and improves survival of mice with OS. In these studies, we used gemcitabine, a nucleoside analog that is effective against various solid tumors. An initial phase I study done in Europe in patients with primary lung cancer demonstrated aerosol gemcitabine therapy to be feasible and safe. In this chapter, we describe different chemotherapeutic agents delivered by inhalation to treat lung diseases with an emphasis on an ongoing study of aerosolized gemcitabine for patients with solid tumors and lung metastases developed at the MD Anderson Cancer Center that uses a convenient approach to track patient lung health with the ultimate goal of implementing this therapy at home.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Perkins SM et al (2014) Outcome for children with metastatic solid tumors over the last four decades. PLoS One 9(7):e100396
Saraf AJ, Fenger JM, Roberts RD (2018) Osteosarcoma: accelerating progress makes for a hopeful future. Front Oncol 8:4
Aylward RB, Burdge DR (1991) Ribavirin therapy of adult respiratory syncytial virus pneumonitis. Arch Intern Med 151(11):2303–2304
Conte JE Jr et al (1990) Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med 113(3):203–209
Ramsey BW et al (1993) Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 328(24):1740–1746
Sharma S et al (2001) Development of inhalational agents for oncologic use. J Clin Oncol 19(6):1839–1847
Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6(8):583–592
Gagnadoux F et al (2008) Aerosolized chemotherapy. J Aerosol Med Pulm Drug Deliv 21(1):61–70
Otterson GA et al (2007) Phase I study of inhaled doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res 13(4):1246–1252
Lemarie E et al (2011) Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. J Aerosol Med Pulm Drug Deliv 24(6):261–270
Kosmidis C et al (2019) Inhaled Cisplatin for NSCLC: facts and results. Int J Mol Sci 20(8)
Zarogoulidis P et al (2012) Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine 7:1551–1572
Cai M, Weng Y (2017) Lung injury following inhaled chemotherapy. Biomed Res India 28(7):3012–3016
Gordon N, Kleinerman ES (2010) Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. J Aerosol Med Pulm Drug Deliv 23(4):189–196
Gagnadoux F et al (2006) Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons. Cancer Chemother Pharmacol 58(2):237–244
Gagnadoux F et al (2005) Safety of pulmonary administration of gemcitabine in rats. J Aerosol Med 18(2):198–206
Knight V et al (2000) Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice. Trans Am Clin Climatol Assoc 111:135–145
Koshkina NV et al (2000) 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res 6(7):2876–2880
Koshkina NV et al (2001) Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 7(10):3258–3262
Koshkina NV, Kleinerman ES (2005) Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer 116(3):458–463
Rodriguez CO Jr et al (2010) Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs. J Aerosol Med Pulm Drug Deliv 23(4):197–206
Tatsumura T et al (1993) Further study of nebulization chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas – fundamental and clinical. Br J Cancer 68(6):1146–1149
Verschraegen CF et al (2004) Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 10(7):2319–2326
Wittgen BPH et al (2007) Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res 13(8):2414–2421
Chou AJ et al (2013) Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. Pediatr Blood Cancer 60(4):580–586
Plunkett W et al (1995) Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol 22(4 Suppl 11):3–10
Poplin E et al (2013) Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity. J Clin Oncol 31(35):4453–4461
Niu J et al (2019) Insight into the role of autophagy in osteosarcoma and its therapeutic implication. Front Oncol 9:1232
Santiago-O’Farrill JM et al (2018) Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy. Oncotarget 9(2):1602–1616
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gordon, N., Felix, K., Daw, N.C. (2020). Aerosolized Chemotherapy for Osteosarcoma. In: Kleinerman, E.S., Gorlick, R. (eds) Current Advances in Osteosarcoma . Advances in Experimental Medicine and Biology, vol 1257. Springer, Cham. https://doi.org/10.1007/978-3-030-43032-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-43032-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-43031-3
Online ISBN: 978-3-030-43032-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)